Suppr超能文献

异位miR-125a表达诱导小鼠和人类造血祖细胞的长期重建造血干细胞能力。

Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors.

作者信息

Wojtowicz Edyta E, Lechman Eric R, Hermans Karin G, Schoof Erwin M, Wienholds Erno, Isserlin Ruth, van Veelen Peter A, Broekhuis Mathilde J C, Janssen George M C, Trotman-Grant Aaron, Dobson Stephanie M, Krivdova Gabriela, Elzinga Jantje, Kennedy James, Gan Olga I, Sinha Ankit, Ignatchenko Vladimir, Kislinger Thomas, Dethmers-Ausema Bertien, Weersing Ellen, Alemdehy Mir Farshid, de Looper Hans W J, Bader Gary D, Ritsema Martha, Erkeland Stefan J, Bystrykh Leonid V, Dick John E, de Haan Gerald

机构信息

Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.

出版信息

Cell Stem Cell. 2016 Sep 1;19(3):383-96. doi: 10.1016/j.stem.2016.06.008. Epub 2016 Jul 14.

Abstract

Umbilical cord blood (CB) is a convenient and broadly used source of hematopoietic stem cells (HSCs) for allogeneic stem cell transplantation. However, limiting numbers of HSCs remain a major constraint for its clinical application. Although one feasible option would be to expand HSCs to improve therapeutic outcome, available protocols and the molecular mechanisms governing the self-renewal of HSCs are unclear. Here, we show that ectopic expression of a single microRNA (miRNA), miR-125a, in purified murine and human multipotent progenitors (MPPs) resulted in increased self-renewal and robust long-term multi-lineage repopulation in transplanted recipient mice. Using quantitative proteomics and western blot analysis, we identified a restricted set of miR-125a targets involved in conferring long-term repopulating capacity to MPPs in humans and mice. Our findings offer the innovative potential to use MPPs with enhanced self-renewal activity to augment limited sources of HSCs to improve clinical protocols.

摘要

脐带血(CB)是用于异基因干细胞移植的造血干细胞(HSCs)的一种便捷且广泛使用的来源。然而,造血干细胞数量有限仍然是其临床应用的主要限制因素。虽然一种可行的选择是扩增造血干细胞以改善治疗效果,但现有的方案以及控制造血干细胞自我更新的分子机制尚不清楚。在此,我们表明,在纯化的小鼠和人类多能祖细胞(MPPs)中异位表达单个微小RNA(miRNA),即miR-125a,可导致移植受体小鼠的自我更新增加和强大的长期多谱系重建。通过定量蛋白质组学和蛋白质印迹分析,我们确定了一组有限的miR-125a靶标,这些靶标赋予人类和小鼠的多能祖细胞长期重建能力。我们的研究结果提供了创新潜力,即使用具有增强自我更新活性的多能祖细胞来增加有限的造血干细胞来源,以改进临床方案。

相似文献

引用本文的文献

2
Loss of ING4 enhances hematopoietic regeneration in multipotent progenitor cells.ING4缺失增强多能祖细胞中的造血再生。
PLoS One. 2025 Feb 14;20(2):e0316256. doi: 10.1371/journal.pone.0316256. eCollection 2025.
5
The Proteogenomics of Prostate Cancer Radioresistance.前列腺癌放射抵抗的蛋白质基因组学研究
Cancer Res Commun. 2024 Sep 1;4(9):2463-2479. doi: 10.1158/2767-9764.CRC-24-0292.
7
Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia.BCR-ABL1 淋巴母细胞白血病的转录组分类。
Nat Genet. 2023 Jul;55(7):1186-1197. doi: 10.1038/s41588-023-01429-4. Epub 2023 Jun 19.

本文引用的文献

1
Advances in umbilical cord blood stem cell expansion and clinical translation.脐带血干细胞扩增及临床转化的进展
Exp Hematol. 2015 Jul;43(7):498-513. doi: 10.1016/j.exphem.2015.04.011. Epub 2015 May 10.
8
Umbilical cord blood transplantation: the first 25 years and beyond.脐带血移植:25 年及以后的发展历程。
Blood. 2013 Jul 25;122(4):491-8. doi: 10.1182/blood-2013-02-453175. Epub 2013 May 14.
9
Umbilical cord blood transplantation: a maturing technology.脐带血移植:一项不断成熟的技术。
Hematology Am Soc Hematol Educ Program. 2012;2012:215-22. doi: 10.1182/asheducation-2012.1.215.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验